Additionally, it is one of three drugs approved to treat obesity in adolescents 12 years and older, with Qsymia and Wegovy being the other two
It refers to emerging research examining how GLP-1 receptor signaling may affect inflammation, hepcidin activity, and iron regulation pathways in chronic disease states
Whether your skin is recovering from environmental damage, acne, or aesthetic procedures, GHK-Cu hastens healing and improves overall skin quality, thereby promoting tissue repair and regeneration
Your PlexusDx provider can help determine whether continuing semaglutide is appropriate or whether an alternative compound like tirzepatide might suit your body better
On an episode of his Ultimate Human Podcast this past December, Gary Brecka, a wellness entrepreneur and a key figure in the MAHA movement, ticked off a half dozen diseases and conditions that he believes BPC-157 can treat
The speed of orforglipron's clinical development from Phase 1 to regulatory submission, spanning approximately 5 years from first-in-human dosing to FDA submission, represents one of the fastest development timelines in obesity pharmacotherapy history
